LSN3318839

CAS No. 2764704-18-7

LSN3318839( —— )

Catalog No. M35703 CAS No. 2764704-18-7

LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be used to lower blood glucose.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 511 In Stock
10MG 738 In Stock
25MG 1121 In Stock
50MG 1479 In Stock
100MG 2018 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LSN3318839
  • Note
    Research use only, not for human use.
  • Brief Description
    LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be used to lower blood glucose.
  • Description
    LSN3318839 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2764704-18-7
  • Formula Weight
    480.39
  • Molecular Formula
    C26H23Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (20.82 mM; Ultrasonic (<60°C)
  • SMILES
    [C@H](C)(N1C=2C(N=C1)=CN=C(C2)C3=C([C@H](C(O)=O)C)C=CC=C3)C4=C(Cl)C(=CC=C4Cl)C5CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Willard FS, et al. Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor. J Med Chem. 2021 Mar 25;64(6):3439-3448.?
molnova catalog
related products
  • CCG-143140

    CCG-143140 is a GLP-1 receptor inverse agonists.

  • HAEGTFT

    HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.

  • Albiglutide TFA

    Albiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).